Aria Pharmaceuticals Overview

  • Founded

  • 2014

Founded
  • Status

  • Private

  • Employees

  • 20

Employees
  • Latest Deal Type

  • Debt - PPP

  • Investors

  • 9

Aria Pharmaceuticals General Information

Description

Operator of an artificial intelligence-driven drug discovery company intended to build a pipeline of therapeutic candidates. The company's firm leverage a computational platform to identify promising drug candidates, de-risks the opportunities through preclinical studies and progresses drug candidates to the clinic through industry and investor partnerships, enabling pharmaceutical companies to boost the traditional methods of drug discovery for rare diseases.

Contact Information

Website
www.ariapharmaceuticals.com
Formerly Known As
twoXAR Pharmaceuticals, twoXAR
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 265 Cambridge Avenue
  • Suite 60099
  • Palo Alto, CA 94306
  • United States
+1 (650) 000-0000

Aria Pharmaceuticals Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aria Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Debt - PPP 16-Apr-2020 000.00 Completed Pre-Clinical Trials
4. Grant 28-Nov-2018 00000 000.00 Completed Pre-Clinical Trials
3. Early Stage VC (Series A) 19-Mar-2018 0000 000.00 0000 Completed Pre-Clinical Trials
2. Seed Round 06-Nov-2015 $4.31M $4.31M 000.00 Completed Pre-Clinical Trials
1. Accelerator/Incubator 24-Jun-2015 Completed Pre-Clinical Trials
To view Aria Pharmaceuticals’s complete valuation and funding history, request access »

Aria Pharmaceuticals Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Seed 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Aria Pharmaceuticals’s complete cap table history, request access »

Aria Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of an artificial intelligence-driven drug discovery company intended to build a pipeline of therapeutic candida
Drug Discovery
Palo Alto, CA
20 As of 2022
000.00
000000000 - 000.00

000000

sequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
0000 000000000
Nottingham, United Kingdom
000 As of 0000
00000000000

000000

re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur
0000 000000000
Toronto, Canada
00 As of 0000
000.00
00000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aria Pharmaceuticals Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sygnature Discovery Private Equity-Backed Nottingham, United Kingdom 000 00000000000
0000000 Venture Capital-Backed Toronto, Canada 00 000.00 00000 000.00
000000000000 Formerly PE-Backed London, United Kingdom 000 00000 000000000 00000
0000000 Venture Capital-Backed San Mateo, CA 0 00.000 00000000000 00.000
00000 000000000000 Corporation Pasadena, CA 0 000.00 000000000 000.00
You’re viewing 5 of 30 competitors. Get the full list »

Aria Pharmaceuticals Executive Team (6)

Name Title Board Seat Contact Info
Andrew Radin Co-Founder, Chief Executive Officer & Board Member
Elizabeth Melendez Chief Of Staff
Andrew Radin Co-Founder & Business Advisor
Jonathan MacQuitty Ph.D Advisor
Vijay Pande Ph.D Scientific Advisor
You’re viewing 5 of 6 executive team members. Get the full list »

Aria Pharmaceuticals Board Members (5)

Name Representing Role Since
Andrew Radin Aria Pharmaceuticals Co-Founder, Chief Executive Officer & Board Member 000 0000
Brian Moriarty Self Board Member 000 0000
Howard Rosen Self Board Member 000 0000
Joonpyo Lee SoftBank Ventures Asia Board Member 000 0000
Jorge Conde Andreessen Horowitz Board Member 000 0000
To view Aria Pharmaceuticals’s complete board members history, request access »

Aria Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aria Pharmaceuticals Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Haya Ghanim Angel (individual) Minority 000 0000 000000 0
OS Fund Venture Capital Minority 000 0000 000000 0
SoftBank Ventures Asia Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial